Gene-Based Analysis in HRC Imputed Genome Wide Association Data Identifies Three Novel Genes For Alzheimer’s Disease

A novel POLARIS gene-based analysis approach was employed to compute gene-based polygenic risk score (PRS) for all individuals in the latest HRC imputed GERAD (N cases=3,332 and N controls=9,832) data using the International Genomics of Alzheimer’s Project summary statistics (N cases=13,676 and N controls=27,322, excluding GERAD subjects) to identify the SNPs and weight their risk alleles for the PRS score. SNPs were assigned to known, protein coding genes using GENCODE (v19). SNPs are assigned using both 1) no window around the gene and 2) a window of 35kb upstream and 10kb downstream to include transcriptional regulatory elements. The overall association of a gene is determined using a logistic regression model, adjusting for population covariates. Three novel gene-wide significant genes were determined from the POLARIS gene-based analysis using a gene window; PPARGC1A, RORA and ZNF423. The ZNF423 gene resides in an Alzheimer’s disease (AD)-specific protein network which also includes other AD-related genes. The PPARGC1A gene has been linked to energy metabolism and the generation of amyloid beta plaques and the RORA has strong links with genes which are differentially expressed in the hippocampus. We also demonstrate no enrichment for genes in either loss of function intolerant or conserved noncoding sequence regions.

[1]  M. O’Donovan,et al.  POLARIS: Polygenic LD‐adjusted risk score approach for set‐based analysis of GWAS data , 2018, Genetic epidemiology.

[2]  Jakob Grove,et al.  Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection , 2018, Nature Genetics.

[3]  M. Owen,et al.  Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[5]  Lei Zhang,et al.  Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach , 2017, Alzheimer's Research & Therapy.

[6]  N. Erginel-Unaltuna,et al.  Identification of potential target genes of ROR‐alpha in THP1 and HUVEC cell lines , 2017, Experimental cell research.

[7]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[8]  Nazanin Mirzaei,et al.  PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model , 2016, Proceedings of the National Academy of Sciences.

[9]  P. Puigserver,et al.  PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors. , 2016, Trends in cancer.

[10]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[11]  Naruya Saitou,et al.  Genomic Locations of Conserved Noncoding Sequences and Their Proximal Protein-Coding Genes in Mammalian Expression Dynamics. , 2016, Molecular biology and evolution.

[12]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[13]  Alessandra Renieri,et al.  Targeted Next‐Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability , 2015, Human mutation.

[14]  G. Kirov,et al.  Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia , 2015, Neuron.

[15]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[16]  M. Fornage,et al.  Association of Alzheimer's disease GWAS loci with MRI markers of brain aging , 2015, Neurobiology of Aging.

[17]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[18]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[19]  H. Lassmann,et al.  Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis , 2014, Acta neuropathologica communications.

[20]  Xiang Gao,et al.  Restored Immunosuppressive Effect of Mesenchymal Stem Cells on B Cells After Olfactory 1/Early B Cell Factor–Associated Zinc‐Finger Protein Down‐Regulation in Patients With Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[21]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[22]  C. Baldwin,et al.  The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology. , 2013, Journal of Affective Disorders.

[23]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[24]  E. Kremmer,et al.  Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia , 2013, The Journal of experimental medicine.

[25]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[26]  G. Kirov,et al.  A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk , 2012, Human molecular genetics.

[27]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[28]  Colin A. Johnson,et al.  Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling , 2012, Cell.

[29]  F. Khodagholi,et al.  ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1α levels in Aβ-injected rats , 2012, Behavioural Brain Research.

[30]  A. Spada,et al.  PGC-1α at the intersection of bioenergetics regulation and neuron function: From Huntington's disease to Parkinson's disease and beyond , 2012, Progress in Neurobiology.

[31]  D. Conrad,et al.  Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia , 2012, Schizophrenia Research.

[32]  A. Ramasamy,et al.  Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies , 2011, Journal of neurochemistry.

[33]  Johnny S. H. Kwan,et al.  GATES: a rapid and powerful gene-based association test using extended Simes procedure. , 2011, American journal of human genetics.

[34]  Thomas W. Mühleisen,et al.  Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.

[35]  J. Mariani,et al.  The nuclear receptor RORα exerts a bi-directional regulation of IL-6 in resting and reactive astrocytes , 2009, Proceedings of the National Academy of Sciences.

[36]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[37]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[38]  A. Jetten.  Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism , 2009, Nuclear receptor signaling.

[39]  Jiandie D. Lin,et al.  Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism , 2007, Nature.

[40]  Eric Raponi,et al.  Zfp423 controls proliferation and differentiation of neural precursors in cerebellar vermis formation , 2006, Proceedings of the National Academy of Sciences.

[41]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[42]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Morton B. Brown.  400: A Method for Combining Non-Independent, One-Sided Tests of Significance , 1975 .

[44]  E. Kremmer,et al.  Aberrant ZNF 423 impedes B cell differentiation and is linked to adverse outcome of ETV 6-RUNX 1 negative B precursor acute lymphoblastic leukemia , 2013 .

[45]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[46]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.